Abstract
ASCO, the American Society of Clinical Oncology, is the largest clinical oncology meeting that meets annually in the USA and is a venue at which new cancer clinical trials and research data are presented. The ASCO 2015 CNS tumors section comprising 3 days of posters and oral presentations and over 70 abstracts provides a contemporary summary of neuro-oncology including metastatic diseases of the CNS as well as primary brain tumors. This brief review selectively highlights presentations from this meeting in an organizational manner that reflects clinically relevant aspects of a large and multifaceted meeting.